ENDO (ENDO) Stock Price & Analysis
ENDO (ENDO) rose 0.00% to USD 0 as of June 10, 2026 at 05:09 UTC, according to Nexqual real-time market data.
ENDO last closed at USD 0; the session ranged USD 0–0 on volume of 500 shares. Market capitalization is $58,793, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 05:09 UTC.
Key Statistics (as of June 10, 2026 at 05:09 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 500 shares |
| Market Cap | $58,793 |
| Exchange | PNK |
Technical Analysis (ENDO)
Nexqual's technical model rates ENDO "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 05:09 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ENDO)
Wall Street analysts rate ENDO "None", per Nexqual as of June 10, 2026 at 05:09 UTC.
| Consensus Rating | None |
|---|
Earnings (ENDO)
Source: Nexqual, June 10, 2026 at 05:09 UTC.
Financials & Fundamentals (ENDO)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0 |
| Total Cash | $59 |
| Total Debt | $954,587 |
Source: Nexqual, June 10, 2026 at 05:09 UTC.
Financial Health Score (ENDO)
Nexqual rates ENDO's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:09 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $59 cash, no debt |
| Cash Flow | Weak — Operating cash flow -$119K |
| Efficiency | Mixed — No data |
Ownership (ENDO)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 587.94M |
| Float | 32.89M |
Source: Nexqual, June 10, 2026 at 05:09 UTC.
Leadership (ENDO)
ENDO is led by Raymond C. Dabney (age 60), President & CEO, per Nexqual as of June 10, 2026 at 05:09 UTC.
| President & CEO | Raymond C. Dabney (age 60) |
|---|---|
| CFO & Director | Robert James Kane (age 49) |
| Head of Technology Development & Director | Anthony Spring |
| Senior VP & Director | Graciela Moreno |
| VP of European Operations & Director | Alfredo Dupetit-Bernardi (age 63) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MNTR | Mentor Capital, Inc. | USD 0.04 | ▲ 0% |
| EAPH | EASTON PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| EDXC | ENDEXX Corp. | USD 0 | ▲ 0% |
| FSPM | FUSION PHARM INC | USD 0 | ▲ 0% |
| CBGI | CANNABUSINESS GROUP INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:09 UTC. This page is informational and not investment advice.